We took advantage of the Zucker diabetic fatty (ZDF) rat model of human type 2 diabetic nephropathy characterized by obesity, hyperlipidemia, insulin resistance, progressive renal injury and cardiac abnormalities [15]–[18] and evaluated the expression of FGF23 in the kidney during the course of the disease. The gene discussed is FGF23; the disease is type 2 diabetes nephropathy.